Dr. Agarwal's Health Care Share Price
508.75-2.70 (-0.53%)
+20.64% past 1 Year
News
Dr. Agarwal's Health Care plans Delhi NCR expansion over next 2 to 3 years
Equity
AGARWALEYE
Dr Agarwal's Health Care to host analyst and investor meet on 16 September
Equity
AGARWALEYE
Dr. Agarwal Health Care reports higher Q1 EBITDA and margin
Equity
AGARWALEYE
Dr. Agarwal'S Health Care posts strong Q1 revenue growth on robust operations
Equity
AGARWALEYE
Dr. Agarwal's Health Care reports higher Q1 net profit year on year
Equity
AGARWALEYE
Dr. Agarwal'S Health Care to host Q1 FY27 earnings call on August 4
Equity
AGARWALEYE
Dr. Agarwal's Health Care’s arm invests $2,00,000 in Orbit Health Care ETH
Equity
AGARWALEYE
Dr. Agarwal's Health - Quaterly Results
Equity
AGARWALEYE
Dr. Agarwal's Health reports Profit after tax of 10.60 Crores, in the March 2026 quarter
Equity
AGARWALEYE
Dr. Agarwals Health Care informs about updates
Equity
AGARWALEYE
Dr. Agarwal's Health Care Terminates Idearx Associate Status Effective March 30, 2026, Retains 14.54% Stake.
Equity
AGARWALEYE
Dr. Agarwals Health Care informs about disclosures
Equity
AGARWALEYE
Dr. Agarwals Health Care informs about disclosure
Equity
AGARWALEYE
Morgan Stanley Maintains Overweight on Dr Agarwal’s Health Care with Rs 596 Target Price.
Equity
AGARWALEYE
Dr. Agarwal's Health Care Q3 FY26 EBITDA Rises 27% YoY to Rs 140 Cr, Margin Expands to 27.17%.
Equity
AGARWALEYE
Dr. Agarwal's Health Care Q3FY26 Net Profit Rises 51% YoY to Rs 33.70 Crores on 23% Revenue Growth.
Equity
AGARWALEYE
Dr. Agarwal's Health reports Profit after tax of 14.06 Crores, in the December 2025 quarter
Equity
AGARWALEYE
Dr Agarwals Health Care informs about disclosure
Equity
AGARWALEYE
Dr. Agarwals Health Care informs about investor presentation
Equity
AGARWALEYE
Dr. Agarwal's Health reports Profit after tax of 4.68 Crores, in the September 2025 quarter
Equity
AGARWALEYE